Two more blood pressure medications recalled over cancer concerns

Several blood pressure medications have been recalled within the last few months, and two more have recently been added to the list.

>> Read more trending news

Teva Pharmaceuticals has voluntarily recalled its amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide combination tablets, the U.S. Food and Drug Administration announced Tuesday.

>> Read the full FDA recall notice

According to a recall notice, the drugs contain too much N-nitroso-diethylamine, a chemical manufactured in Mylan, India. The ingredient, typically found in certain foods, drinking water and air pollution, has been classified as a human carcinogen by the International Agency for Research on Cancer. 

>> Yet another blood pressure medication recalled over cancer risk

Teva officials noted the company has not received any reports of illness, but it has asked its retailers to stop distributing the products and return them immediately. 

Patients on the medications are advised to continue taking the tablets and to contact their doctor for advice for alternate treatments. An official with the company said, “the risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any comparable alternative treatment.”

>> Common blood pressure medication linked to greater lung cancer risk, study says

The agency recently recalled three other blood pressure medications due to cancer concerns, and another was recalled for mislabeling.

Thank you for reading the Dayton Daily News and for supporting local journalism. Subscribers: log in for access to exclusive deals and newsletters.

Thank you for supporting in-depth local journalism with your subscription to the Dayton Daily News. Get more news when you want it with email newsletters just for subscribers. Sign up here.

X